{
  "retracted": false,
  "timestamp": 1552953600000,
  "updates": [
    {
      "timestamp": 1585096245605,
      "identifier": {
        "doi": "10.1073/pnas.1902633116"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1073/pnas.1814027116"
  },
  "publisher": "Proceedings of the National Academy of Sciences",
  "title": "Correction for Li et al., Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors"
}
